Explanted vein grafts with an intact endothelium demonstrate reduced focal expression of endothelial nitric oxide synthase specific to atherosclerotic sites

Journal of Pathology

Volumn 179, Issue 2, 1996, Pages 197-203

  Buttery, Lee D K ^a   Chester, Adrian H ^b   Springall, David R ^a   Borland, Julie A A ^b   Michel, Thomas ^c   Yacoub, Magdi H ^b   Polak, Julia M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

atherosclerosis; endothelium; graft; nitric oxide synthase; saphenous vein

Indexed keywords

NITRIC OXIDE SYNTHASE; VON WILLEBRAND FACTOR;

ANTIGEN SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXPLANT; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; REOPERATION; SAPHENOUS VEIN; VEIN GRAFT;

ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOENZYME TECHNIQUES; NITRIC OXIDE SYNTHASE; SAPHENOUS VEIN; SUBSTRATE SPECIFICITY;

EID: 0029994360     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199606)179:2<197::AID-PATH587>3.0.CO;2-D     Document Type: Article

References (36)

1. Favoloro RG. Saphenous vein autograft replacement of severe sequential coronary artery occlusion: operative technique. Ann Thorac Surg 1968; 5: 334-339.
2. Hall RJ, Elayda MA, Gray A, et al. Coronary artery bypass: long-term follow up of 22.284 consecutive patients. Circulation 1983; 68: 1120-26.
3. Loop FD, Lytle BW, Gill CG, et al. Trends in selection and results of coronary artery re-operation. Ann Thorac Surg 1983; 36: 380-388.
4. Grondin CM, Lesperance J, Bourassa MG, Pasternac A, Campeau L, Grondin P. Serial angiographic evaluation in 60 consecutive patients with aorto-coronary vein grafts 2 weeks. 1 year and 3 years after operation. J Thorac Cardiovasc Surg 1974; 67: 1-6.
5. Grondin CM, Campeau L, Lesperance J, Enjabert M, Bourassa MG. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation 1984; 70: 208-212.
6. Malone JM, Kischer CW, Moore WS. Changes in venous endothelium fibrinolytic activity and histology with in vitro venous distension and arterial implantation. Am J Surg 1981; 142: 178-186.
7. Campeau L, Enjalbert M, Lesperance J, et al. The relationship of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. A study 10 years after surgery. N Engl J Med 1984; 311: 1329-1332.
8. Ku DD, Caulfield JB, Kirklin JK. Endothelium-dependent responses in long-term human coronary bypass grafts. Circulation 1991; 83: 401-411.
9. O'Neil GS, Chester AH, Schyns CJ, et al. Effect of surgical preparation and arterialization on vasomotion of human saphenous vein. J Thorac Cardiovasc Surg 1994; 107: 699-706.
10. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
11. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
12. Mao S, Yates M, Lambert L, et al. Nitric oxide protects against the oxidative modification of low density lipoprotein by macrophages. FASEB 1992; 6: A1030.
13. Angelini GD, Christie MI, Bryan AJ, Lewis MJ. Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann Thorac Surg 1989; 48: 417-420.
14. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub S. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990; 336: 897-900.
15. Forstermann U. Properties and mechanisms of production and action of endothelium-derived relaxing factor. J Cardiovasc Pharmacol 1986; 8 (Suppl 10): 545-551.
16. Marsden PA, Schappert KT, Chen Hai S, et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 1992; 307: 287-293.
17. Michel T, Li KG, Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1993; 90: 6252-6256.
18. Buttery LDK, McCarthy A, Springall DR, et al. Endothelial nitric oxide synthase in human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994; 15: 257-265.
19. Shu S, Ju G, Fan L. The glucose-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988; 85: 167-171.
20. Clinton J, Forsyth C, Royston MC, Roberts GW. Synaptic degeneration is the primary neuropathological feature in prion disease. A preliminary study. Neuroreport 1993; 4: 65-68.
21. Hofer H, Mitatsch MJ, Guggenheim R, Amsler B, Horse J, Graedel E. Morphological studies in saphenous vein grafts for aorto-coronary bypass surgery - Part 1. Morphology of the graft using ordinary surgical preparation techniques. J Thorac Cardiovasc Surg 1981; 29: 32-37.
22. Lawrie GM, Lie JT, Morris GC Jr, Beazley HL. Vein graft patency and intimal proliferation after aorto-coronary bypass: early and long term angio-pathologic correlations. Am J Cardiol 1976; 38: 856-862.
23. Luscher TF, Yang Z, Oemar. Endothelium and vascular smooth muscle function of coronary bypass grafts. In: Luscher TF, Turina M, Braunwald E, eds. Coronary Artery Graft Disease (Mechanisms and Prevention).
24. Barboriak JJ, Pintar K, Korns ME. Atherosclerosis in aortocoronary vein grafts. Lancet 1974; 2: 621-624.
25. Kalan JM, Roberts WC. Morphologic findings in saphenous vein used as coronary arterial bypass conduits for longer than one year: necropsy analysis of 53 patients, 123 saphenous veins and 1865 five millimetre segments of veins. Am Heart J 1990; 119: 1104-1184.
26. Walton KW, Slaney G, Ashton F. Atherosclerosis in vascular grafts for peripheral vascular disease. Part 1. Autogenous vein grafts. Atherosclerosis 1985; 54: 49-64.
27. Luscher TF, Diederich D, Siebermann R. Difference between endothelium-dependent relaxation in arterial and venous coronary bypass grafts. N Engl J Med 1988; 319: 462-467.
28. Bulkey BH, Hutchins GM. Accelerated atherosclerosis: a morphological study in 97 saphenous vein grafts. Circulation 1977; 55: 163-169.
29. Chester AH, Buttery LDK, Borland JAA, et al. Effect of distension pressure on presence and activity of nitric oxide synthase in human saphenous vein. J Thorac Cardiovasc Surg (submitted).
30. Fuchs JCA, Mitchener JS, Hagen P. Postoperative changes in autologous vein grafts. Ann Surg 1978; 188: 1-15.
31. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by I.-arginine. Lancet 1991; 338: 1546-1550.
32. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumour necrosis factor downregulates endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993; 73: 205-209.
33. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 391-324.
34. Ross R. Atherosclerosis: a defence mechanism gone awry. Am J Pathol 1993; 143: 987-1002.
35. Nabel EG, Plaitz, Boyce FM, Tranley JC, Nabel GC. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989; 244: 1342-1344.
36. Wilson JM, Biriyani LK, Salomon RN, Libby P, Callow AD, Mulligan RC. Implantation of vascular grafts with genetically modified endothelial cells. Science 1989; 244: 1344-1346.